News

Stocks turned in a mixed performance on Thursday, extending a winning streak for one major index and ending one for another, ...
U.S. stocks are set to wrap a winning week as tariff and trade fears ease, President Trump winds down his Middle East trip securing billions of investments for the U.S. and Warren Buffett’s Berkshire ...
Thursday closed up +0.41%, the Dow Jones Industrials Index ($DOWI) (DIA) closed up +0.65%, and the Nasdaq 100 Index ($IUXX) ...
The Dow and S&P 500 gained Thursday as the stock market weighed retail earnings and economic data. The Nasdaq fell, snapping its six-day win streak.
In case SP500 manages to settle above the resistance at 5910 – 5920, it will head towards the next resistance level at 6000 – 6010. NASDAQ is mostly flat as traders take some profits off the table ...
The three major US indices that I am following here all look as if they are trying to give back some of the froth in the overall markets. At this point, the market is a little overdone, but at this ...
The blue-chip Dow was up over 150 points in afternoon trade, shaking off a lower open, as a big chunk of losses in shares of retail giant Walmart were erased. Shares of Walmart were down almost 5% in ...
S&P 500 futures are down 0.5%. Dow Jones Industrial Average futures are off 0.4%. Nasdaq 100 futures are slipping 0.6%. On Wednesday, the Dow Jones Industrial Average fell 89 points, or 0.21%, to ...
U.S. stocks were trimming their early losses on Thursday, with both the Dow and the S&P 500 turning higher ahead of midday. Shares of stocks that had weighed heavily on both equity gauges were staging ...
Trump’s tariffs and trade deals continue to affect global markets. Follow along for live updates on the Dow, S&P 500 and Nasdaq.
Stocks were trading near session highs in afternoon trade, resuming the rally sparked earlier in the week by the partial U.S.-China tariff pause. "Investors are getting more comfortable with the ...
Back home, shares of Hyundai Motor India, Bharat Heavy Electricals, Emami, Delhivery, and Jubilant Pharmova will be in focus ...